[Implantation of defibrillators with transvenous-subcutaneous electrode systems].
In 23 patients an integrated pacemaker-defibrillator-system with transvenous-subcutaneous lead system was implanted. Two transvenous electrodes were positioned, one in the right ventricle for sensing, pacing and defibrillation and one in the superior vena cava for defibrillation alone. Another electrode was positioned subcutaneously near the ventricular apex for defibrillation. In 22 patients (96%) the lead system could be implanted without a major complication. The defibrillation threshold for ventricular fibrillation was 16 +/- 5 joules. During follow up of 6 +/- 4 months all spontaneous tachyarrhythmias were successfully terminated. There were three complications during follow up. In 2 patients the transvenous electrode dislocated and one patient showed a sensing malfunction. In conclusion the non-thoracotomy approach is effective, reduces the perioperative risk and represents therefore a great advantage compared to peri-/epicardial lead system.
Hief
C
C
Medizinische Abteilung mit Kardiologie, Ludwig-Boltzmann-Institut für Arrhythmieforschung, Wilhelminenspital, Wien.
Podczeck
A
A
Veit
F
F
Frohner
K
K
Kaltenbrunner
W
W
Nürnberg
M
M
Steinbach
K
K
D000368:Aged; D002311:Cardiomyopathy, Dilated / Q000628:therapy; D003327:Coronary Disease / Q000628:therapy; D017147:Defibrillators, Implantable; D004562:Electrocardiography; D004567:Electrodes, Implanted; D004867:Equipment Design; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017180:Tachycardia, Ventricular / Q000628:therapy*; D014693:Ventricular Fibrillation / Q000628:therapy*